EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Select category

ANNOUNCEMENTS SHAREHOLDER INFORMATION

Select time

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Date

Title

File

Times

2021-04-19

NEXT DAY DISCLOSURE RETURN

2319

2021-04-12

NEXT DAY DISCLOSURE RETURN

2342

2021-04-07

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021

2084

2021-04-07

INSIDE INFORMATION APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE MOXIFLOXACIN HYDROCHLORIDE EYE DROPS IN THE PRC

2173

2021-03-26

NEXT DAY DISCLOSURE RETURN

2213

2021-03-25

NEXT DAY DISCLOSURE RETURN

2255

2021-03-25

NOTICE OF ANNUAL GENERAL MEETING

2236

2021-03-25

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 12 MAY 2021 (or any adjournment thereof)

2108

2021-03-25

PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING

2260

2021-03-24

NEXT DAY DISCLOSURE RETURN

2058

2021-03-23

NEXT DAY DISCLOSURE RETURN

2109

2021-03-19

VOLUNTARY ANNOUNCEMENT FURTHER UPDATE IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

2036

2021-03-12

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020

2249

2021-03-02

NOTICE OF BOARD MEETING

2104

2021-03-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2021

2058

2021-03-01

CHANGE OF ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER AGENT IN THE CAYMAN ISLANDS

1941

2021-02-24

INSIDE INFORMATION FURTHER UPDATES IN RELATION TO CO-DEVELOPMENT AGREEMENT - POSITIVE OUTCOME OF U.S. FDA SECOND PHASE 3 CLINICAL TRIAL IN DRY EYE DISEASE

2026

2021-02-22

NSIDE INFORMATION FURTHER UPDATES IN RELATION TO CO-DEVELOPMENT AGREEMENT - U.S. FDA SECOND PHASE 3 CLINICAL TRIAL ("VISTA-2") IN DRY EYE DISEASE

2050

2021-02-22

NEXT DAY DISCLOSURE RETURN

2200

2021-02-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2021

2107

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT